Journal
AAPS JOURNAL
Volume 11, Issue 1, Pages 23-30Publisher
SPRINGER
DOI: 10.1208/s12248-008-9073-0
Keywords
delivery; endothelial cells; genes; lung; oligonucleotides; pulmonary circulation; siRNA; targeting
Categories
Funding
- National Institutes of Health Grants [HL-63080, HL-68688]
- American Heart Association Grant [026540U]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063080, R01HL068688] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Targeted delivery of functional nucleic acids (genes and oligonucleotides) to pulmonary endothelium may become a novel therapy for the treatment of various types of lung diseases. It may also provide a new research tool to study the functions and regulation of novel genes in pulmonary endothelium. Its success is largely dependent on the development of a vehicle that is capable of efficient pulmonary delivery with minimal toxicity. This review summarizes the recent progress that has been made in our laboratory along these research directions. Factors that affect pulmonary nucleic acids delivery are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available